Brief: Xenitra Announces A$12M Offtake Agreement With Leading OTC-Pharmaceutical
27/07/2026 02:46
BRIEF-Xenitra Announces A$12M Offtake Agreement With Leading OTC-Pharmaceutical July 27 (Reuters) - Xenitra Ltd XEN.AX:
$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL
SIGNS THREE-YEAR PHARMACEUTICAL PROCUREMENT AGREEMENT WITH KANGSHENG
ALL FIGURES IN AUD
INITIAL COMMERCIAL ORDERS EXPECTED TO COMMENCE THIS QUARTER
Further company coverage: XEN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xenitra
See all newsBrief: Xenitra To Raise A$1.5 Million Via Placement Of 500 Million Shares At A$0.003 Each
Brief: Xenitra Seeks Trading Halt For Material Capital Raising
Brief: Xenitra Announces A$12M Offtake Agreement With Leading OTC-Pharmaceutical
Brief: Xenitra Says OPAL RWA-Tokenised Product Sales Eclipse A$1 MLN In Just 7 Weeks
Brief: Xenitra Ltd Says It Will Raise A$1.25 Million Via Placement